Partner Sites

Scott Ripley

Scott Ripley is the general manager of the nucleic acid therapeutics business for Cytiva, leading the global commercial go-to-market strategy. Scott has more than 20 years of experience across research and bioprocess businesses, including a recent focus on the mRNA domain.

Articles by Scott Ripley

Illustration of an mRNA molecule against a dark blue background.
|3 min read

Overcoming mRNA Process Challenges

For mRNA technology to reach its full potential, innovations in manufacturing are needed
byScott Ripley
Page 1 of 1
1

Sponsored

Social

Your Model From Our Experience: Cloud First Digital Pathology in a High-Volume Regional Laboratory  

Sponsored by
A clinician holds a AI chip surrounded by digital healthcare icons, representing the use of artificial intelligence in clinical diagnostics

Ensuring Compliance: How to Get AI Diagnostic Tools Approved for Clinical Practice

Sponsored by
Two researchers working in a diagnostic lab with advanced testing solutions

Cutting-Edge Gastrointestinal Pathogen Testing Technologies for Labs

Sponsored by
Screenshot

The Path to Absolute Quantification in Gene Expression

Sponsored by